Evidence map›Paper›PMID 40433507›Full record

ArticleDrugs in context2025

Real-world use of a hydrophilic curcumin-based oral formulation in the management of macular oedema: a collection of clinical experiences.

Davide Allegrini, Giuseppe Covello, Alessandra Mancini, Antonino Mancini, Maura Mancini, Mary Romano, Aldo Vecchiarelli, Mario R Romano

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drugs in context, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Davide AllegriniEye Clinic Humanitas Gavazzeni Castelli, Bergamo, Italy.
Giuseppe Covello *Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
Alessandra Mancini *Department of Ophthalmology, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Antonino Mancini *Mancini Eye Clinic, Taurianova, Reggio Calabria, Italy.
Maura Mancini *Department of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy.
Mary Romano *Multidisciplinary Department of Medical, Surgical and Dental Sciences University of Campania Luigi Vanvitelli, Naples, Italy.
Aldo Vecchiarelli *Ospedale IRCCS Neuromed, Pozzilli, Isernia, Italy.
Mario R RomanoEye Clinic Humanitas Gavazzeni Castelli, Bergamo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a collection of clinical experiences exploring the real-world effectiveness of a hydrophilic curcumin-based oral formulation (CHC, Diabec

Indexed as

central serous chorioretinopathycurcumin-based therapydiabetic macular oedemahydrophilic carrier curcuminmacular oedema

Identifiers

PMID40433507
PMCPMC12108699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.